Telemus Capital’s Northwest Biotherapeutics NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-32,401
Closed -$18K – 365
2016
Q3
$18K Buy
32,401
+17,909
+124% +$8.19K ﹤0.01% 340
2016
Q2
$8K Buy
+14,492
New +$15.5K ﹤0.01% 340

Other funds holding NWBO

Telemus Capital's NWBO Position: Q4 2016 in Review

Telemus Capital sold out of Northwest Biotherapeutics (NWBO) in Q4 2016, closing a stake of 32,401 shares — an estimated $18K sold.

Telemus Capital first reported a position in NWBO in Q2 2016 and held it in 2 quarters. The position peaked at $18K in Q3 2016. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Telemus Capital reported no remaining Northwest Biotherapeutics position as of Q4 2016 after selling out during the quarter.
  • Telemus Capital sold 32,401 Northwest Biotherapeutics shares in Q4 2016, an estimated $18K.
  • Telemus Capital first reported a position in Northwest Biotherapeutics in Q2 2016 and held it in 2 quarters.
  • Telemus Capital's Northwest Biotherapeutics position peaked at $18K in Q3 2016.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q4 2016.

Based on Telemus Capital's 13F filing for Q4 2016, filed 24 Jan 2017.